YU49193A - 17-BETA-ESTRADIOL TRANSDERMAL THERAPY SYSTEM WITH ACTIVE MATERIAL - Google Patents

17-BETA-ESTRADIOL TRANSDERMAL THERAPY SYSTEM WITH ACTIVE MATERIAL

Info

Publication number
YU49193A
YU49193A YU49193A YU49193A YU49193A YU 49193 A YU49193 A YU 49193A YU 49193 A YU49193 A YU 49193A YU 49193 A YU49193 A YU 49193A YU 49193 A YU49193 A YU 49193A
Authority
YU
Yugoslavia
Prior art keywords
beta
active material
therapy system
estradiol
active substance
Prior art date
Application number
YU49193A
Other languages
Serbo-Croatian (sh)
Inventor
M. Horstmann
M. Kursawe
H. Dzekan
Original Assignee
Lts Lohmann Therapie - Systeme Gmbh. And Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie - Systeme Gmbh. And Co.Kg. filed Critical Lts Lohmann Therapie - Systeme Gmbh. And Co.Kg.
Priority to YU49193A priority Critical patent/YU49193A/en
Publication of YU49193A publication Critical patent/YU49193A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pronalazak se odnosi na transdermalni terapijski sistem koji sadrži aktivnu materiju 17-beta-estradiol i u datom slučaju osim toga aktivne materije, sa slojevitom izgradnjom na zadnjem sloju u suštini nepropusnim za aktivnu materiju i vlagu, jednim ili više slojeva matrice i u datom slučaju lepljivim slojem, nazanačen time, što najmanje jedan od slojeva matrice ili lepljivi sloj sadrži bezvodni 17-beta-estradiol u kristalnom obliku.The invention relates to a transdermal therapeutic system comprising the active substance 17-beta-estradiol and optionally in addition the active substance, with a layered back layer substantially impermeable to the active substance and moisture, one or more layers of the matrix and optionally a sticky layer. characterized in that at least one of the matrix layers or the adhesive layer contains anhydrous 17-beta-estradiol in crystalline form.

YU49193A 1993-07-15 1993-07-15 17-BETA-ESTRADIOL TRANSDERMAL THERAPY SYSTEM WITH ACTIVE MATERIAL YU49193A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU49193A YU49193A (en) 1993-07-15 1993-07-15 17-BETA-ESTRADIOL TRANSDERMAL THERAPY SYSTEM WITH ACTIVE MATERIAL

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU49193A YU49193A (en) 1993-07-15 1993-07-15 17-BETA-ESTRADIOL TRANSDERMAL THERAPY SYSTEM WITH ACTIVE MATERIAL

Publications (1)

Publication Number Publication Date
YU49193A true YU49193A (en) 1996-08-13

Family

ID=47556970

Family Applications (1)

Application Number Title Priority Date Filing Date
YU49193A YU49193A (en) 1993-07-15 1993-07-15 17-BETA-ESTRADIOL TRANSDERMAL THERAPY SYSTEM WITH ACTIVE MATERIAL

Country Status (1)

Country Link
YU (1) YU49193A (en)

Similar Documents

Publication Publication Date Title
FI961282A0 (en) Transdermal therapeutic system with acetylsalicylic acid as active ingredient
DK1014954T3 (en) Transdermal therapeutic system
DE59006461D1 (en) Therapeutic system for the delayed and controlled transdermal or transmucosal administration of active substances (II).
ATE179328T1 (en) TRANSDERMAL THERAPEUTIC SYSTEM WITH THE ACTIVE INGREDIENT 17-ESTRADIOL (ANHYDROUS)
YU69693A (en) TRANSDERMAL THERAPY SYSTEM WITH ACTIVE MATERIAL ESTRADIOL
YU49193A (en) 17-BETA-ESTRADIOL TRANSDERMAL THERAPY SYSTEM WITH ACTIVE MATERIAL
FR2012584A1 (en) Surgical and other materials adhering to skin
ATE173163T1 (en) ESTRADIOL-TTS WITH WATER-BINDING ADDITIVES
CA2172401A1 (en) Transdermal therapeutic system with acetylsalicylic acid as active substance